Navigation Links
Lanx, Inc. Announces Aspen™ Spinous Process Fixation System Clinical Data at IMAST
Date:7/25/2011

BROOMFIELD, Colo., July 25, 2011 /PRNewswire/ -- Lanx®, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, announced its Aspen™ Spinous Process Fixation System (Aspen) was featured in two poster presentations at The 18th International Meeting on Advanced Spine Techniques (IMAST) in Copenhagen, Denmark, July 13th to 16th.

Dan Gladney, Chief Executive Officer, Lanx, commented, "These scientific sessions at IMAST add to our growing body of data that continue to validate the versatility and efficacy of the Aspen system as a viable alternative to pedicle screw-rod fixation, as well as an effective adjunct to fusion. We see great opportunity in the spinous process fixation market and plan to leverage our leadership position to expand our platform with this proven, proprietary technology."

At the meeting, Dr. Mitchell Hardenbrook of The Boston Spine Group in collaboration with Colorado State University presented "Rigid Spinous Process System Fixation vs. Pedicle Screw Fixation in a Posterolateral Lumbar Arthrodesis Construct – Comparison of Fusion Rates." In this study, 24 sheep underwent a posterolateral fusion procedure at L5-L6, with autograft placed between the transverse processes. Twelve received the Aspen device and 12 received a bilateral pedicle screw-rod construct. Within 6 months following surgery CT analysis showed 12 of 12 sheep in the Aspen device group with robust bridging bone on at least one side, whereas only 7 of 12 in the pedicle screw group showed the same degree of bridging bone on at least one side.

Also at the meeting, Dr. Dean G. Karahalios of North Shore University Health System in collaboration with Barrow Neurological Institute presented "Biomechanics of Lumbar Facet Screws and Interspinous Anchor." The study compared the biomechanics of five different constructs combining facet screws, pedicle screws and the Aspen device, evaluating flexion-extension, lateral bending and axial rotation. In the combined average range of motion, both the Aspen device with bilateral facet screws and bilateral pedicle screws provided statistically superior stability.

To date, over 800 spine surgeons have used the Aspen system in nearly 20,000 implantations to achieve lumbar fusion in a less invasive manner than pedicle screws. The system includes a proprietary spiked fixation plate designed to be rigidly affixed to the spinous processes with the use of specialized surgical instrumentation. The unique central barrel allows the device to share the weight found in the lumbar and thoracic spine, while its hollow and fenestrated design serves as a bone graft containment chamber to facilitate fusion.

The Aspen system is intended for single level use in the thoracic or lumbar spine (T1-S1) for the treatment of degenerative disc disease, spondylolisthesis, spinal trauma or spinal tumor. The Aspen system is currently being used in a wide range of surgical applications including posterior fusions and interbody fusions.

Lanx markets a full line of spine stabilization technologies. For more information about the Aspen system or Lanx, please visit www.lanx.com.

About Lanx, Inc.Lanx is one of the largest and fastest growing privately held global spine companies. The Company was founded by a team of experienced medical device professionals and engineers in 2003 to improve the quality of spine care and provide surgeons with innovative products. Lanx develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. The Company is headquartered in Broomfield, CO. More information on Lanx and its spinal surgery products can be found at www.lanx.com.Company Contact:

Media / Investors:Steve Deitsch

Kim Muscara / Nick LaudicoChief Financial Officer

(646) 536-7011/ 7030(303) 443-7500

kmuscara@theruthgroup.comsteve.deitsch@lanx.com

nlaudico@theruthgroup.com
'/>"/>

SOURCE Lanx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lanx, Inc. Announces Launch of Epic™ Anterior Thoracolumbar Plating System
2. Lanx, Inc. Appoints Dan Gladney Chief Executive Officer
3. Prasco® Announces Authorized Generic Agreement with Shionogi Inc.
4. Cornerstone Pharmaceuticals Announces The Journal of Molecular Medicines Publication of Research Showing Selective Inhibition of Cancer Cell Energy Metabolism With Its Novel Lipoate Derivative Compounds
5. SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestones Achieved
6. Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
7. Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
9. China Nuvo Solar Announces Definitive Agreement Signed to Acquire Medical Products company SurgLine, Inc.
10. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
11. Misonix Announces Settlement of PuriCore Litigation, Including Entry into a U.S. Distribution Agreement for PuriCores Advanced Wound Care Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , 22. März 2017   ... und weltweit tätige Anbieter von Produkten und ... den Erwerb von EPL Archives Inc. bekannt, ... der Kunden im kompletten Zyklus regulierter Forschung, ... von Proben, Speicherung von Dokumenten und Zusatzdienstleistungen ...
(Date:3/22/2017)... 2017 TapImmune, Inc. (NASDAQ: ... development of innovative peptide and gene-based immunotherapeutics for ... announced that it will participate in two upcoming ... Glynn Wilson , Chairman and CEO of TapImmune, ... clinical pipeline and partnering opportunities for its proprietary ...
(Date:3/22/2017)... 22, 2017 A new independent study ... the proven ultraviolet-C (UV-C) disinfection solution of choice ... Published in the March issue ... , the peer-reviewed study of UV-C disinfection systems ... General Hospital and Rochester General Hospital. According to ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... Donor ... and Nevada and LABS, Inc., announced the future opening of a CLIA certified ... and serology testing used to determine the suitability of potential organ and ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... solution provider, today announced that its digital marketing solutions have enabled Children’s Hospital ... investment in 24 months. , Recognizing the value of a digital marketing ...
(Date:3/22/2017)... ... March 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, ... to accept new patients in need of skilled pediatric dentistry in Rock ... Care offers pediatric patients routine treatments, including cavities, sealants and fluoride applications, in a ...
(Date:3/22/2017)... Milford, PA (PRWEB) , ... March 22, 2017 , ... ... producers, according to a US Department of Agriculture report. While excess dairy can ... sensitivity play a role. Lactose sensitivity is the inability to properly digest lactose, a ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... financial consultations to families and business owners in the greater Hampton Roads area, ... American Cancer Society Relay For Life event. , Each year, hundreds of people ...
Breaking Medicine News(10 mins):